NASDAQ:ABEO

Abeona Therapeutics Stock Insider Trading

etoro logo Buy ABEO
*Your capital is at risk
$5.69
+0.0600 (+1.07%)
At Close: Jun 02, 2026

Abeona Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -75.38. In total, the insiders bought 1.59M and sold 1.02M ABEO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-75.38
Buy 1.59M shares
Sell 1.02M shares
33% Buy Activity
Weak Positive Correlation
Sell Signal Medium Confidence
Jan 22, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -75.38.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 21, 2026
Sell
Common Stock
S-Sale
Alvino Mark
Director
Director 13 500
Value: $70.6K
Jan 20, 2026
Buy
Common Stock
A-Award
Vasanthavada Madhav
Chief Commercial Officer
Officer 76 621
Value: $406.9K
Jan 20, 2026
Buy
Common Stock
A-Award
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 133 595
Value: $709.4K
Jan 20, 2026
Buy
Common Stock
A-Award
Seshadri Vishwas
Chief Executive Officer
CEO / President 365 422
Value: $1.94M
Jan 20, 2026
Buy
Common Stock
A-Award
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 113 949
Value: $605.1K
Jan 01, 2026
Buy
Employee Stock Option (right to buy)
Vasanthavada Madhav
Chief Commercial Officer
Officer 2 400
Value: $10K
Jan 01, 2026
Buy
Common Stock
Vasanthavada Madhav
Chief Commercial Officer
Officer 0
Value: $0
Dec 29, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 25 000
Value: $132.7K
Nov 13, 2025
Sell
Common Stock
S-Sale
Alvino Mark
Director
Director 15 000
Value: $71.2K
Oct 16, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 249
Value: $1K
Sep 30, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 25 000
Value: $130.9K
Sep 30, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 25 000
Value: $130.9K
Sep 29, 2025
Sell
Common Stock
S-Sale
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 9 366
Value: $50.5K
Sep 29, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 19 274
Value: $104.0K
Sep 29, 2025
Sell
Common Stock
S-Sale
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 9 035
Value: $48.7K
Sep 29, 2025
Sell
Common Stock
S-Sale
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 9 035
Value: $48.7K
Sep 29, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 19 274
Value: $104.0K
Sep 29, 2025
Sell
Common Stock
S-Sale
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 9 366
Value: $50.5K
Sep 22, 2025
Sell
Common Stock
S-Sale
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 688
Value: $4K
Sep 22, 2025
Sell
Common Stock
S-Sale
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 688
Value: $4K
Aug 15, 2025
Sell
Common Stock
S-Sale
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 15 000
Value: $110.4K
Aug 15, 2025
Sell
Common Stock
S-Sale
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 15 000
Value: $110.4K
Aug 14, 2025
Sell
Common Stock
S-Sale
Crombez Eric
Director
Director 4 718
Value: $32.7K
Aug 14, 2025
Sell
Common Stock
S-Sale
Crombez Eric
Director
Director 4 718
Value: $32.7K
Jul 22, 2025
Sell
Common Stock
S-Sale
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 1 502
Value: $10K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE